Jeffrey S. Heier serves as Executive at OCULAR THERAPEUTIX, INC, where they oversee executive responsibilities. Since joining the company, Jeffrey S. Heier has executed 8 insider transactions totaling $365.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 23, 2026 involved selling 3,057 shares valued at $25.3K.
Jeffrey S. Heier currently holds 323,368 shares of OCULAR THERAPEUTIX, INC (OCUL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey S. Heier has been a net seller of OCUL stock. They have purchased $145.3K and sold $219.9K worth of shares.
Jeffrey S. Heier's most recent insider trade was on Feb 23, 2026, when they sold 3,057 shares at $8.28 per share.
Get notified when new Form 4 filings are submitted
| $12.04 |
| Discretionary |
| Oct 2, 2025 | OCUL | $115.9K | Sale | 10,502 | $11.04 | Discretionary |
| Aug 25, 2025 | OCUL | $36.9K | Sale | 3,063 | $12.04 | Discretionary |
| Jun 14, 2023 | OCUL | $0 | Award | 12,000 | $N/A | Discretionary |
| Jun 16, 2022 | OCUL | $0 | Award | 8,933 | $N/A | Discretionary |
| May 12, 2022 | OCUL | $45.8K | Purchase | 15,000 | $3.05 | Discretionary |
| Mar 15, 2019 | OCUL | $99.6K | Purchase | 24,000 | $4.15 | Discretionary |